Syntax Advisors’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$271K Sell
825
-96
-10% -$30.2K 0.24% 93
2023
Q2
$277K Sell
921
-117
-11% -$33.6K 0.22% 90
2023
Q1
$278K Buy
1,038
+233
+29% +$67K 0.21% 92
2022
Q4
$266K Sell
805
-29
-3% -$9.85K 0.22% 98
2022
Q3
$275K Sell
834
-148
-15% -$47.7K 0.24% 88
2022
Q2
$275K Buy
982
+151
+18% +$45.6K 0.23% 90
2022
Q1
$277K Buy
+831
New +$256K 0.23% 97

Other funds holding MOH

Syntax Advisors's MOH Position: Q3 2023 in Review

Syntax Advisors reduced its Molina Healthcare (MOH) stake by 10% in Q3 2023, selling an estimated $30.2K and leaving 825 shares worth $271K. The position accounts for 0.24% of the portfolio, ranked #93.

Syntax Advisors first reported a position in MOH in Q1 2022 and has held it in 7 quarters since. The position peaked at $278K in Q1 2023. 563 funds tracked by Wall St. Rank hold MOH as of Q3 2023.

  • Syntax Advisors held 825 shares of Molina Healthcare worth $271K as of Q3 2023.
  • Syntax Advisors sold 96 Molina Healthcare shares in Q3 2023, an estimated $30.2K.
  • Molina Healthcare made up 0.24% of Syntax Advisors's portfolio in Q3 2023, its #93 holding.
  • Syntax Advisors first reported a position in Molina Healthcare in Q1 2022 and has held it in 7 quarters since.
  • Syntax Advisors's Molina Healthcare position peaked at $278K in Q1 2023.
  • 563 funds tracked by Wall St. Rank held Molina Healthcare as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.